Press Releases

LogiPharma Unveils 2024 Agenda Featuring Big Pharma Players

LogiPharma, the world's largest life sciences supply chain event has unveiled its highly anticipated 2024 agenda, spotlighting key themes and speakers for this year's show, which takes place in Lyon, France, 16th – 18th April.

CD Formulation Excels in Developing and Optimizing Micro-Reservoir Controlled-Release Drug Delivery Systems

Alfa Chemistry Introduces Bio-based Polymers, Responding to Market Demand

Huateng Pharma Launches Veterinary Solutions – Fluralaner and Sarolaner

Huateng Pharma offers Fluralaner (CAS NO.:864731-61-3) and Sarolaner (CAS NO.:1398609-39-6) from laboratory-scale development to commercial production.

Biopharma PEG Unveils Expanded Azide PEG Series

Biopharma PEG, a leading provider of polyethylene glycol (PEG) derivatives, is proud to introduce an extended Azide PEG series that includes monodispersed, polydispersed, and multi-arm PEGs.

Evoke unveils simplified brand and structure: Inizio Evoke Delivers more connected solutions for clients to address demands of dynamic global healthcare marketplace

Inizio Evoke will unite its specialty agencies and capabilities to offer services across marketing, comms, transformation, media and access

Bora Pharmaceuticals to Acquire US Pharma Manufacturer Upsher-Smith for $210 Million in Transaction to Fuel Global Expansion

Digital Health Panel Developer Verisense Health Appoints New Engineering Manager in Malaysia

Chong Toh Ying has more than 16 years’ experience managing large datasets and building and leading software engineering teams that deliver fast and accurate results.

CD Formulation Newly Launches Dissolving Microneedle Preparation Services: Enhancing Drug Delivery Efficiency

Alfa Chemistry Newly Announces Offering of Click Chemistry Reagents: Azides, Terminal Alkynes, and Copper-Chelating Ligands

Modular automation solution adds PACE to just-in-time clinical trials packing

A new modular automation system for clinical trials drug delivery – now in operation at the Medical Manufacturing Innovation Centre (MMIC) in Strathclyde – is giving pharmaceutical and life sciences a game-changing insight into a future where new products can be delivered faster, more flexibly and cheaper than before.

Andelyn Biosciences and Armatus Bio Partner to Manufacture Suspension-Based AAV Gene Therapy for Rare Neurological Disease Charcot-Marie-Tooth Type 1A (CMT1A)

Andelyn Biosciences and Armatus Bio are partnering to accelerate the manufacturing of a suspension-based AAV gene therapy for Charcot-Marie-Tooth Type 1A (CMT1A), a rare neurological disease. The collaboration aims to maximize program efficiency and speed up clinical studies using Andelyn's expertise in AAV production and suspension platform. The initiative brings hope to patients with unmet needs in neuromuscular diseases.

New Multi-Hospital Partner Joins OneMedNet’s Expansive Real World Data Network

OneMedNet Corporation announced a partnership with Beacon Health System, Inc. to promote new patient care diagnostic and treatment solutions using OneMedNet’s iRWD™. Life Science organizations of all types are taking advantage of existing real world data within several product development stages including conceptualization, development, validation, regulatory approval, and post-market surveillance. The OneMedNet iRWD network consists of over 235 healthcare systems and providers who are well-recognized for their exceptional patient care.

Blue Spark Technologies Adds MaryAnne Rizk to Board of Advisors

Blue Spark Technologies, Inc., a proven innovative digital health technology (DHT) leader in enabling AI-powered remote patient monitoring (RPM) to support precision patient-centric drug development, proudly announces the appointment of Dr. MaryAnne Rizk, a recognized leader in drug development technological innovation, to the Company’s advisory board.

Bio-Link and Verdot Forge Strategic Partnership to Advance Bioprocessing Technologies in China

I wanted to reach out with the latest news from Verdot, who have recently forged a strategic partnership with Bio-Link, a prominent Chinese bioprocessing company. The collaboration aims to advance biopharmaceutical manufacturing in China, with Bio-Link becoming the major distributor for Verdot’s innovative chromatography columns in the Chinese market The full release and images are below. Thank you Charlotte

CD Genomics Unveils Groundbreaking Total RNA Sequencing and Dual RNA-seq Services

CD Genomics Introduces Advanced OxBS-seq Technology for Accurate Methylation Analysis

Alkermes Announces Topline Results From Long-Term, Open-Label Safety and Durability of Treatment Effect Study of LYBALVI® (olanzapine and samidorphan)

— Results Demonstrated that LYBALVI was Generally Well Tolerated With Stability of Body Weight and Metabolic Profile, and Durable Symptom Control, for Up to Four Years of Treatment —

Elligo Health Research Announces New CEO

John Potthoff Transitions to Chairman, Barry Simms Promoted to CEO

Mundipharma announces European approval of REZZAYO® (rezafungin) for the treatment of Invasive Candidiasis in adults

Mundipharma announces European approval of REZZAYO® (rezafungin) for the treatment of Invasive Candidiasis in adults. Approval based on positive results from the pivotal ReSTORE Phase III clinical trial and supported by the STRIVE Phase II clinical trials and extensive nonclinical development program.1,2 Rezafungin represents the first new treatment option in over 15 years for patients with invasive candidiasis.3